News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
Eckert & Ziegler SE partners with Telix Pharmaceuticals for ProstACT GLOBAL Phase III study, serving as European CMO and supplier of Lu-177, aiming to advance prostate cancer treatment -
-
COMMUNIQUÉ DE PRESSE
Reduction of Resources for the Liquidity Contract Agreement with Rothschild Martin Maurel
Reduction of resources in liquidity contract agreement between ATOS SE and Rothschild Martin Maurel to 2 million euros with updated minimum balance requirement. Compliance with market regulations -
-
COMMUNIQUÉ DE PRESSE
DEFENCE THERAPEUTICS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER ADVANCES
Defence Therapeutics collaborates with Orano to develop targeted radio-immunotherapy for cancer, aiming to advance treatment efficacy with novel technology -
-